9.980GBp+1.01%Mkt Cap: 626.92M GBpP/E: —Last update: 2026-05-13
Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally.…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 167.7
58.14BTRYP/E 27.8
51.02BEURP/E 20.1
13.68BEURP/E 31.2
13.35BTRY—
13.10BSEKP/E 39.5
3.09BTRY—
3.02BEURP/E 25.0
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-13.47
PEG—
P/B97.00
P/S10.72
EV/EBITDA-19.38
EV/Revenue10.69
EPS (TTM)-0.01
EPS (Forward)-0.01
Cash Flow & Leverage
FCF Yield-3.86%
FCF Margin-42.18%
Operating CF-28.11M GBp
CapEx (TTM)3.42M GBp
Net Debt/EBITDA-0.53
Net Debt16.67M GBp
Technical
SMA 5010.57 (-5.6%)
SMA 2009.955 (+0.2%)
Beta0.89
S&P 52W Chg24.23%
Avg Vol (30d)233.42K
Avg Vol (10d)210.27K
Technical Indicators
RSI (14)45.2
MACD-0.1909
MACD Signal-0.1283
MACD Hist.-0.0626
BB Upper11.33 GBp
BB Middle10.48 GBp
BB Lower9.635 GBp
BB Width16.13%
ATR (14)1.317 GBp
Vol Ratio (20d)0.56x
52W Range
6.50062% of range12.10
52W High12.10 GBp
52W Low6.500 GBp
Profitability
Gross Margin53.23%
EBITDA Margin-55.16%
Profit Margin-72.91%
Oper. Margin-31.35%
ROE142.35%
ROA-59.42%
Revenue Growth6.60%
Earnings Growth—
Balance Sheet
Debt/Equity-2.13
Current Ratio1.13
Quick Ratio0.70
Book Value/Sh0.0010 GBp
Cash/Share0.0020 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.6.33B
Float703.13M
Insiders88.42%
Institutions0.00%
Analyst Consensus
Rating—
Target (Mean)13.00 GBp
Target Range13.00 GBp – 13.00 GBp
# Analysts1
Company
Market Cap626.92M GBp
Enterprise Value612.39M GBp
Revenue (TTM)57.29M GBp
Gross Profit29.30M GBp
Net Income (TTM)-40.13M GBp
Revenue/Share0.0110 GBp
Fiscal Year EndJun 2025
MR QuarterDec 2025
Employees584
Last Price9.980 GBp
CountryGB
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—